Mechanisms of Acquired Resistance and Tolerance to EGFR Targeted Therapy in Non-Small Cell Lung Cancer

SIMPLE SUMMARY: Lung cancer is the major cause of cancer-related deaths worldwide. The development of targeted therapies has dramatically improved the outcome of lung cancer patients. However, despite an initial response, tumors almost invariably relapse as a result of acquired resistance. In this r...

Descripción completa

Detalles Bibliográficos
Autores principales: Chhouri, Houssein, Alexandre, David, Grumolato, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856371/
https://www.ncbi.nlm.nih.gov/pubmed/36672453
http://dx.doi.org/10.3390/cancers15020504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856371/
https://www.ncbi.nlm.nih.gov/pubmed/36672453
http://dx.doi.org/10.3390/cancers15020504

Ejemplares similares